a developer of novel therapeutics for serious unmet medical needs
Industry Biotechnology
A.I.dvisor indicates that over the last year, ATRA has been closely correlated with AMLX. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if ATRA jumps, then AMLX could also see price increases.
Ticker / NAME | Correlation To ATRA | 1D Price Change % | ||
---|---|---|---|---|
ATRA | 100% | -10.39% | ||
AMLX - ATRA | 68% Closely correlated | -2.70% | ||
GRI - ATRA | 38% Loosely correlated | -0.41% | ||
SLRX - ATRA | 37% Loosely correlated | -9.64% | ||
NTLA - ATRA | 36% Loosely correlated | -3.65% | ||
FULC - ATRA | 35% Loosely correlated | -5.26% | ||
More |
Ticker / NAME | Correlation To ATRA | 1D Price Change % |
---|---|---|
ATRA | 100% | -10.39% |
ATRA (3 stocks) | 97% Closely correlated | +0.85% |
stem cells (21 stocks) | 36% Loosely correlated | +0.41% |
therapeutics (57 stocks) | 20% Poorly correlated | +20.54% |
drugs (265 stocks) | 17% Poorly correlated | +5.37% |
biotechnology (248 stocks) | 14% Poorly correlated | +5.56% |